Goldman Sachs Stock Declines Following Major Transaction and Favorable Regulatory Proposal
Shares of The Goldman Sachs Group Inc. (NYSE:GS) experienced a decline, with the stock price at $790.91, a decrease of $14.59 or 1.81%. The movement follows the disclosure of a significant stock transaction by the spouse of Senator Ted Cruz and a proposal by U.S. regulators to relax a key capital rule for major banks.
A transaction involving Goldman Sachs shares, valued between $100,001 and $250,000, was made by Ted Cruz's spouse on November 11, 2025, and disclosed the following day. This event coincided with news of a potential regulatory change that could benefit the financial institution.
U.S. regulators have agreed to a proposal that would ease the enhanced Supplementary Leverage Ratio (SLR), a part of the Basel III capital framework. This adjustment is expected to reduce total capital requirements for the depository units of large banks, including Goldman Sachs, by up to 27%. The proposal has been sent to the White House for review and aims to provide banks with more flexibility in lending and Treasury trading.
On the NYSE, Goldman Sachs saw a trading volume of 2,043,245 shares. The stock's price for the day fluctuated between a low of $778 and a high of $800.13. Over the past year, the stock has traded as high as $841.28 and as low as $439.38. The company currently has a market capitalization of approximately $248.1 billion.
The Goldman Sachs Group, Inc. (GS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.